Nilo Therapeutics
New York, US · Founded 2024 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
JG
Jeff GoaterExecutive Officer, Director
TK
Tim KutzkeyExecutive Officer, Director, Promoter
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$9.6MraisedAug 2024 · 3 investors · BiotechnologyRule 506(b)
▶$9.6MraisedAug 2024 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tim KutzkeyExecutive Officer, Director, Promoter
- Jeff GoaterExecutive Officer, Director
- Offering amount
- $101M
- Amount sold
- $9.6M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.